Studies on dopaminergic and GABAergic markers in striatum reveals a decrease in the dopamine transporter in schizophrenia

Schizophrenia Research

Volumn 52, Issue 1-2, 2001, Pages 107-114

  Dean, Brian ^a,b,c   Hussain, Tabasum ^a,c  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Dopamine receptors; Dopamine transporter; GABAA receptor; Nitric oxide synthase; Schizophrenia; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE TRANSPORTER; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CELL INTERACTION; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; FEMALE; GABAERGIC SYSTEM; HUMAN; HUMAN TISSUE; INNERVATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; RECEPTORS, DOPAMINE; RECEPTORS, GABA; SCHIZOPHRENIA;

EID: 0035476358     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00096-7     Document Type: Article

References (42)

1. Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters and serotonin1A receptors
2. Nitric oxide synthase-containing neurons in the human hypothalamus: Reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics
3. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
4. Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
5. Extrapyramidal syndromes
6. Dopamine receptors in human brain: Autoradiographic distribution of D1 sites
7. The basal ganglia
8. 3H]GBR 12935 binding to dopamine uptake sites in post-mortem brain tissue in schizophrenia
9. Changes in serotonin2A and GABA(A) receptors in schizophrenia: Studies on the human dorsolateral prefrontal cortex
10. G-nitro-L-arginine labelling to measure cerebellar nitric oxide synthase in patients with schizophrenia
11. 11C]raclopride
12. Neuroleptic equivalence
13. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia - A post-mortem study
14. 3H]muscimol binding in autopsied brains of chronic schizophrenics
15. 3H]nemonapride
16. 3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin
17. Dopamine receptor subtype imbalance in schizophrenia
18. Post-mortem brain studies in schizophrenia: The problems of diagnosis
19. 3H]mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranes
20. Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia
21. Dopamine in schizophrenia
22. Nitric oxide synthase (NOS) in schizophrenia: Increases in cerebellar vermis
23. Tissue pH as an indicator of mRNA preservation in human post-mortem brain
24. Quantitative autoradiography of dopamine D1 receptors, D2 receptors, and dopamine uptake sites in post-mortem striatal specimens from schizophrenic patients
25. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects
26. Dopamine receptors and schizophrenia: Drug effect or illness?
27. 76Br-bromolisuride
28. Biological studies in schizophrenia
29. Distribution of putative D4 dopamine receptors in post-mortem striatum from patients with schizophrenia
30. Frontal-striatal cognitive deficits in patients with chronic schizophrenia
31. Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia
32. 3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease
33. Status of the dopaminergic system in post-mortem brain in schizophrenia
34. Dopamine receptors and schizophrenia: The neuroleptic drug problem
35. Brain dopamine transporter: Gender differences and effect of chronic haloperidol
36. Presence of sigma and phencyclidine (PCP)-like receptors in membrane preparations of bovine adrenal medulla
37. 3H]WIN 35,428 to central dopamine transporters
38. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's diseases
39. Dopamine D4 receptors elevated in schizophrenia
40. An improved approach to prepare human brains for research